Last Price
2.40
Today's Change
+0.455 (23.39%)
Day's Change
2.32 - 2.70
Trading Volume
37,623,772
Overview
Market Cap
3 Billion
Shares Outstanding
1 Billion
Avg Volume
6,988,134
Avg Price (50 Days)
1.65
Avg Price (200 Days)
1.33
PE Ratio
239.50
EPS
0.01
Earnings Announcement
20-Mar-2025
Previous Close
1.95
Open
2.52
Day's Range
2.32 - 2.7
Year Range
0.650025 - 2.7
Trading Volume
37,627,218
Price Change Highlight
1 Day Change
23.14%
5 Day Change
21.57%
1 Month Change
17.40%
3 Month Change
93.15%
6 Month Change
85.66%
Ytd Change
139.50%
1 Year Change
309.90%
3 Year Change
391.88%
5 Year Change
297.84%
10 Year Change
253.64%
Max Change
-10.97%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Medical Distribution
Description:
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates approximately 1,200 branded and independent pharmacy stores under the Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also provides hospital pharmacy wholesale services; dose administration aid services to the aged care sector, community pharmacy sector, and in the home; technology solutions and data analytics; and product development and support for a range of private and exclusive label products, as well as supplies medical consumables and devices to a broad range of customers, including pharmacy aged care facilities, hospitals, and clinics. In addition, it offers contract logistics services to pharmaceutical manufacturers and other supplier partners. Sigma Healthcare Limited was founded in 1912 and is headquartered in Rowville, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
RBA Holds Key Rate at 13-year High as World Waits on US Vote
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
